de la Rosette, Jean http://orcid.org/0000-0002-6308-1763
Martov, Alexey
Hurle, Rodolfo
Favre, Gabriel
Mamoulakis, Charalampos
Castanheira de Oliveira, Manuel
Stenzl, Arnulf
Linares-Espinós, Estefania
Trelles Guzmán, Carlos R.
Gravas, Stavros
Knoll, Thomas
Boz, Mustafa Yucel
Herrmann, Thomas
Laguna, Pilar
Funding for this research was provided by:
karl storz company
Article History
Received: 18 June 2021
Accepted: 16 October 2021
First Online: 6 November 2021
Declarations
:
: Jean de la Rosette: none, Pilar Laguna: none, Thomas Herrmann: Company Consultant, Honoraria, Stipendium, Research Collaboration and Grant—Karl Storz; Advisory board, honoraria—Boston Scientific; Advisory, Research Collaboration, Honoraria—Lisa Laser GmbH, Alexey Martov: none, Charalampos Mamoulakis: none, Thomas Knoll: Speaker/Advisor Karl Storz Endoscopes—Manuel Castanheira de Oliveira: none, Mustafa Yucel Boz: none, Stavros Gravas: none, Linares-Espinós: none, Trelles Guzmán: none, Arnulf Stenzl: Ad Board/Consultant, Ipsen Pharma, Roche; Ad Board/Consultant, Janssen; Ad Board/Synergo; Ad Board/Ferring; Ad Board/Astellas; Ad Board/AstraZeneca; Institution Research grant, Amgen Inc; Institution Research grant, Ipsen Pharma; Institution Research grant, Karl Storz AG.
: The trial was registered at ClinicalTrials.gov (Identifier NCT02252549). The trial was approved by the ethics committee of the Amsterdam UMC (NL50451.018.14), University of Amsterdam, Amsterdam, the Netherlands.
: The trial was performed in accordance to the Declaration of Helsinki. Patients were included after information and signing of the informed consent form.